SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-046256
Filing Date
2020-10-13
Accepted
2020-10-13 08:30:20
Documents
12
Period of Report
2020-10-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-8k_20201013.htm   iXBRL 8-K 35072
  Complete submission text file 0001564590-20-046256.txt   164637

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20201013.xsd EX-101.SCH 5772
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20201013_lab.xml EX-101.LAB 19480
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20201013_pre.xml EX-101.PRE 11629
5 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-8k_20201013_htm.xml XML 3563
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 201234723
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences